Investing legend Rob Arnott shares 3 unloved stocks he’s betting on right now
Rob Arnott’s career has been built on exploiting inefficiencies in stock indexes.
That ethos isn’t changing at Syzygy Asset Management, the rebranded firm Arnott unveiled after selling his Research Affiliates indexing business to VettaFi in August.
So far, Syzygy has launched three long-short strategies: its core, growth, and value portfolios.
While they vary, each strategy generally looks for large companies, as measured by sales volume, that trade at reasonable or cheap valuations. By filtering by sales volume rather than market cap, the firm aims to avoid smaller firms with sky-high valuations.
This differs from other major indexes, which tend to organize their holdings by market cap. While the thinking is that they give investors exposure to the economy’s largest stocks, market cap alone does not capture how large a firm’s top line actually is, leaving investors vulnerable to overpaying, Arnott argues.
Here’s a further breakdown of the philosophy and investment criteria behind each of Syzygy’s strategies:
- Core: This is supposed to be an all-market, S&P 500-esque strategy. The main difference is that Syzygy uses the 500 largest companies by sales growth, rather than by market cap, which helps eliminate small firms with high valuations.
- Growth: Takes the top 500 companies by sales volume, and then whittles them down to those that fall in the top 25% of sales growth, profit growth, and R&D spending. Arnott’s gripe with other growth indexes is that they tend to require higher valuations as key characteristics of growth stocks. This strategy counts fast-growing firms as growth stocks even if their valuations are cheap.
- Value: This is similar to the core strategy, but is more “extremely focused” on value, Arnott said. Syzygy looks at quality and momentum metrics, in addition to valuation measures, to determine what constitutes a good value buy. These help an investor avoid “value traps,” or buying a declining company just because it is cheap.
3 stocks Arnott likes right now
Arnott shared a few of the long positions in his portfolio right now, with two of them falling into the growth category. Those include banking giant JPMorgan (JPM) and pharmaceutical company Merck (MRK).
Both firms’ growth stories are underappreciated by mainstream factor indexes, Arnott said.
Want more Business Insider in your news feed?
Add BI in Google so our reporting is easier to find when you’re searching for what matters.
“Merck and JPMorgan are the fastest-growing large businesses that aren’t in Russell growth, or at least aren’t in Russell Growth at full weight,” he said.
The third stock is in Syzygy’s core strategy: the world’s largest producer of natural gas, Cheniere Energy (LNG).
Cheniere is not part of the S&P 500, and Arnott put its size in context with firms in the index that generate lower sales.
“Last year it had 5 times the revenues of Palantir and was trading at 1/5 the market value, so 1/25 the valuation multiple,” Arnott said.
Here’s how the three stocks above are valued, and how they’ve performed over the last year: